TDAI core faculty Macarius Donneyong (College of Pharmacy and College of Public Health) has been invited to serve as a member of the National Academies of Sciences, Engineering, and Medicine (NASEM) Committee on Strategies to Better Align Investments in Innovations for Therapeutic Development with Disease Burden and Unmet Needs. 

The formal charge to the committee is to examine the current degree and patterns of alignment or mismatch between innovation in developing novel therapies and unmet needs associated with US disease burden (including high-impact, low-frequency diseases as well as highly prevalent conditions). The committee will recommend strategies to spur and facilitate increased innovation to address unmet needs and reduce health disparities.

In addition to reviewing the published literature and publicly available information sources, the committee will identify and engage appropriate stakeholders, including relevant federal agencies (e.g., NIH, ARPA-H, FDA, CMS), the academic/professional community of researchers and clinicians, private industry, and patient/consumer groups, to gain their perspectives as input to committee deliberations. Based on the information gathered, the committee will identify the challenges, opportunities, and responsibilities in building both public and private capacity for innovation in therapeutic development and ensuring broad, equitable access to safe and effective novel therapies.

Read more about the committee members and their charge